ActivePure airborne-virus research

COVID, RSV & Monkeypox Peer-Review

Research supporting indoor air quality and infection control.

The study

Tested against three aerosolized viruses.

Researchers at the University of Texas Medical Branch evaluated ActivePure Technology against aerosolized SARS-CoV-2, respiratory syncytial virus and monkeypox virus.

The study compared a device equipped with ActivePure Technology against a control device without the technology. Viral concentrations were measured before and after activation.

Key findings

Rapid reductions under study conditions.

SARS-CoV-2

>99.83%

within one minute

The virus associated with COVID-19

RSV

>99.98%

within one minute

Respiratory syncytial virus

MPXV

>99.63%

within five minutes

Monkeypox virus

Key takeaway

A potential tool for cleaner indoor environments.

The peer-reviewed findings support the potential value of ActivePure Technology as part of indoor air-quality and infection-control strategies, particularly in high-risk occupied environments.